Int Diag Hld Share Price (IDHC)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Int Diag Hld	LSE:IDHC	London	Ordinary Share	JE00BV9H9G76	ORD USD1.00

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+$0.10	+2.17%	$4.70	91,790	16:29:01

Bid Price		Offer Price	High Price	Low Price	Open Price
$4.50		$4.70	$4.70	$4.50	$4.50

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	84.19	31.43	14.68	32.1	705.5

Int Diag Hld (IDHC) Latest News

Int Diag Hld News

Date	Time	Source	Headline
21/3/2019	09:55	ALNC	Integrated Diagnostics Hikes Payout As Annual Profit, Revenue Jump
21/3/2019	07:19	ALNCF	Alliance News Flash Headline
21/3/2019	07:01	UKREG	Integrated Diagnostics Holdings PLC Final Results
07/3/2019	07:02	UKREG	Integrated Diagnostics Holdings PLC Appointment of a Broker
05/3/2019	07:02	UKREG	Integrated Diagnostics Holdings PLC Notice of Results
01/3/2019	16:09	UKREG	Integrated Diagnostics Holdings PLC Holding(s) in Company
31/12/2018	13:27	UKREG	Integrated Diagnostics Holdings PLC Holding(s) in Company
17/12/2018	09:46	ALNC	Georgia Healthcare Opens Mega Laboratory With Integrated Diagnostics
17/12/2018	09:06	UKREG	Integrated Diagnostics Holdings PLC Agreement with Georgia Healthcare Group
21/11/2018	12:16	ALNC	Integrated Diagnostics' Walk-In Segment Proves Biggest Growth Boost

More Int Diag Hld News

Int Diag Hld Takeover Rumours

Int Diag Hld (IDHC) Share Charts

1 Year Int Diag Hld Chart

1 Month Int Diag Hld Chart

Intraday Int Diag Hld Chart

Int Diag Hld (IDHC) Discussions and Chat

Int Diag Hld Forums and Chat

Date	Time	Title	Posts
21/3/2019	07:59	Integrated Diagnostics	7
19/8/2018	19:55	Integrated Diagnostics (IDHC) One to Watch on Monday	-

Add a New Thread

Int Diag Hld (IDHC) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
16:35:12	4.70	982	4,615.40	UT
16:29:01	4.70	1,197	5,625.90	AT
16:20:30	4.50	5,359	24,115.50	AT
16:20:30	4.50	3,573	16,078.50	AT
16:19:38	4.70	1,052	4,944.40	AT

View all Int Diag Hld trades in real-time

Int Diag Hld (IDHC) Top Chat Posts

Date	Subject
26/3/2019 08:20	Int Diag Hld Daily Update: Int Diag Hld is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker IDHC. The last closing price for Int Diag Hld was US$4.60. Int Diag Hld has a 4 week average price of US$3.75 and a 12 week average price of US$3.75. The 1 year high share price is US$5 while the 1 year low share price is currently US$3.30. There are currently 150,112,360 shares in issue and the average daily traded volume is 234,649 shares. The market capitalisation of Int Diag Hld is £705,528,092. Read Full Thread Reply
11/10/2016 07:12	ncooper1: rambutan2, thank you for your post. I will read your links. however, I was not suggesting Egypt is in a 'right mess'. I am not qualified to make such an assessment: sadly, I have not even visited Egypt yet although I do plan to. My point re currency devaluation was more factual. It has depreciated relative to US$. Do you have any views on IDHC? Do you agree my thesis above, that IDHC is fundamentally good and that its share price is being unduly impacted by Egypt and currency movements? Read Full Thread Follow Reply
10/10/2016 16:54	ncooper1: I'd welcome views as to why IDHC share price continues to fall. Fundamentals seem good, and the only obvious areas is Egypt being unsettled (but this is not new news). Currencies need to be considered too: essentially Egyptian Pound depreciating vs US$ and also £ depreciating relative to US$. My understanding is that the former should not impact IDHC input costs to the extent of share price fall-and the latter should mean the share price should increase, I think!? I've personally continued to add, but views sought. Read Full Thread Follow Reply
06/9/2016 17:05	rambutan2: Of course, we are talking Egypt here: Commenting on the half-year performance and the company's outlook, IDH Chairman Lord St John of Bletso said: "I am pleased to report that your Company has continued to perform up to market expectations despite challenges regarding the availability of foreign exchange in Egypt that, compounded by rising inflation, have had a knock-on impact on consumer spending. Egypt has recently arrived at a staff-level agreement for a three-year, USD 12 billion extended fund facility with the International Monetary Fund. Provided this is approved by the IMF's executive board, we anticipate that the implementation of the reform package it requires will bring some stability to the Egyptian Pound. We continue to invest in expanding our business in Egypt and are also exploring opportunities to expand the business into other high-growth markets." IDH Chief Executive Officer Dr. Hend El-Sherbini added: "Despite challenges in Egypt, our largest market, we have been successful in growing the business and maintaining our margins. In the second half of the year, we will continue to target revenue growth of 15% while maintaining EBITDA margins in our historical range of 43-45%. We have negotiated moderate price increases with key suppliers that will take effect in 2H2016 and invested after Ramadan in a targeted marketing campaign to drive recurring test revenue. We also continue to invest in expanding our branch network to reach new patients as we explore growth opportunities outside Egypt." http://uk.advfn.com/stock-market/london/int-diag-hld-IDHC/share-news/Integrated-Diagnostics-Holdings-PLC-Half-year-Repo/72267096 Read Full Thread Follow Reply

Int Diag Hld share price data is direct from the London Stock Exchange

Your Recent History

LSE

IDHC

Int Diag H..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20190326 21:02:12